Android app on Google Play

RBC Capital Initiates Coverage on Drug Manufacturer Stocks AGN & ENDP

September 17, 2010 9:10 AM EDT Send to a Friend
Get Alerts AGN Hot Sheet
Price: $133.92 --0%

Rating Summary:
    16 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade AGN Now!
Join SI Premium – FREE
RBC Capital initiates coverage on Allergan (NYSE: AGN) with an Outperform rating. PT $77.

RBC initiates coverage on Endo Pharmaceuticals (Nasdaq: ENDP) with a Sector Perform rating. PT $30.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

RBC Capital

Add Your Comment